156 related articles for article (PubMed ID: 7937561)
1. Physical stability and protein stability of freeze-dried cakes during storage at elevated temperatures.
Izutsu K; Yoshioka S; Kojima S
Pharm Res; 1994 Jul; 11(7):995-9. PubMed ID: 7937561
[TBL] [Abstract][Full Text] [Related]
2. Decreased protein-stabilizing effects of cryoprotectants due to crystallization.
Izutsu K; Yoshioka S; Terao T
Pharm Res; 1993 Aug; 10(8):1232-7. PubMed ID: 8415413
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the physical stability of freeze-dried sucrose-containing formulations by differential scanning calorimetry.
te Booy MP; de Ruiter RA; de Meere AL
Pharm Res; 1992 Jan; 9(1):109-14. PubMed ID: 1589394
[TBL] [Abstract][Full Text] [Related]
4. Freeze-Drying of L-Arginine/Sucrose-Based Protein Formulations, Part 2: Optimization of Formulation Design and Freeze-Drying Process Conditions for an L-Arginine Chloride-Based Protein Formulation System.
Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
J Pharm Sci; 2015 Dec; 104(12):4241-4256. PubMed ID: 26422647
[TBL] [Abstract][Full Text] [Related]
5. Effects of formulation and process factors on the crystal structure of freeze-dried Myo-inositol.
Izutsu K; Yomota C; Okuda H; Kawanishi T; Yamaki T; Ohdate R; Yu Z; Yonemochi E; Terada K
J Pharm Sci; 2014 Aug; 103(8):2347-55. PubMed ID: 24916801
[TBL] [Abstract][Full Text] [Related]
6. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
[TBL] [Abstract][Full Text] [Related]
7. Effect of co-solutes and process variables on crystallinity and the crystal form of freeze-dried myo-inositol.
Izutsu KI; Kusano R; Arai R; Yoshida H; Ito M; Shibata H; Sugano K; Goda Y; Terada K
Int J Pharm; 2016 Jul; 509(1-2):368-374. PubMed ID: 27282535
[TBL] [Abstract][Full Text] [Related]
8. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins III: collapse during storage at elevated temperatures.
Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
Eur J Pharm Biopharm; 2013 Oct; 85(2):240-52. PubMed ID: 23727369
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of polymers PVP90 and Ficoll400 on storage stability and viability of Lactobacillus coryniformis Si3 freeze-dried in sucrose.
Schoug Å; Mahlin D; Jonson M; Håkansson S
J Appl Microbiol; 2010 Mar; 108(3):1032-1040. PubMed ID: 19735322
[TBL] [Abstract][Full Text] [Related]
10. Miscibility as a factor for component crystallization in multisolute frozen solutions.
Izutsu KI; Shibata H; Yoshida H; Goda Y
J Pharm Sci; 2014 Jul; 103(7):2139-2146. PubMed ID: 24903048
[TBL] [Abstract][Full Text] [Related]
11. Stability of beta-galactosidase, a model protein drug, is related to water mobility as measured by 17O nuclear magnetic resonance (NMR).
Yoshioka S; Aso Y; Izutsu K; Terao T
Pharm Res; 1993 Jan; 10(1):103-8. PubMed ID: 8430045
[TBL] [Abstract][Full Text] [Related]
12. Systematic investigation of the effect of lyophilizate collapse on pharmaceutically relevant proteins, part 2: stability during storage at elevated temperatures.
Schersch K; Betz O; Garidel P; Muehlau S; Bassarab S; Winter G
J Pharm Sci; 2012 Jul; 101(7):2288-306. PubMed ID: 22517663
[TBL] [Abstract][Full Text] [Related]
13. Prevention of high-temperature-induced chromosome damage in mouse spermatozoa freeze-dried using Ca
Kusakabe H; Tateno H
Cryobiology; 2017 Dec; 79():71-77. PubMed ID: 28863951
[TBL] [Abstract][Full Text] [Related]
14. Investigation of PEG crystallization in frozen and freeze-dried PEGylated recombinant human growth hormone-sucrose systems: implications on storage stability.
Bhatnagar BS; Martin SWH; Hodge TS; Das TK; Joseph L; Teagarden DL; Shalaev EY; Suryanarayanan R
J Pharm Sci; 2011 Aug; 100(8):3062-3075. PubMed ID: 21491456
[TBL] [Abstract][Full Text] [Related]
15. Effect of sucrose/raffinose mass ratios on the stability of co-lyophilized protein during storage above the Tg.
Davidson P; Sun WQ
Pharm Res; 2001 Apr; 18(4):474-9. PubMed ID: 11451034
[TBL] [Abstract][Full Text] [Related]
16. Effects of formulation and process variables on the aggregation of freeze-dried interleukin-6 (IL-6) after lyophilization and on storage.
Lueckel B; Helk B; Bodmer D; Leuenberger H
Pharm Dev Technol; 1998 Aug; 3(3):337-46. PubMed ID: 9742554
[TBL] [Abstract][Full Text] [Related]
17. Effect of process conditions on recovery of protein activity after freezing and freeze-drying.
Jiang S; Nail SL
Eur J Pharm Biopharm; 1998 May; 45(3):249-57. PubMed ID: 9653629
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of trehalose and cations on the thermal resistance of beta-galactosidase in freeze-dried systems.
Mazzobre MF; Del Pilar Buera M
Biochim Biophys Acta; 1999 Dec; 1473(2-3):337-44. PubMed ID: 10594371
[TBL] [Abstract][Full Text] [Related]
19. Stability Studies of a Freeze-Dried Recombinant Human Epidermal Growth Factor Formulation for Wound Healing.
Santana H; García G; Vega M; Beldarraín A; Páez R
PDA J Pharm Sci Technol; 2015; 69(3):399-416. PubMed ID: 26048746
[TBL] [Abstract][Full Text] [Related]
20. Freeze-drying of HESylated IFNα-2b: Effect of HESylation on storage stability in comparison to PEGylation.
Liebner R; Bergmann S; Hey T; Winter G; Besheer A
Int J Pharm; 2015 Nov; 495(1):608-611. PubMed ID: 26387618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
